These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4548551)

  • 1. Anticonvulsant activity of delta9-tetrahydrocannabilol and its 11-hydroxy and 8alpha, 11-dihydroxy metabolites in the frog.
    Karler R; Cely W; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):441-52. PubMed ID: 4548551
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of the development of tolerance to an anticonvulsant effect of delta9-tetrahydrocannabinol and cannabidiol.
    Karler R; Cely W; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):23-39. PubMed ID: 4438826
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticonvulsant properties of cannabidiol.
    Turkanis SA; Cely W; Olsen DM; Karler R
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):231-46. PubMed ID: 4850602
    [No Abstract]   [Full Text] [Related]  

  • 4. The interaction of delta9-tetrahydrocannabinol and d-amphetamine in aggregated mice.
    Craigmill AL; Canafax DM; Curtiss FR
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):229-41. PubMed ID: 4438830
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative activity of delta9-tetrahydrocannabinol, diphenylhydantoin, phenobarbital and chlordiazepoxide on electroshcok seizure threshold in mice.
    Sofia RD; Barry H
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):73-8. PubMed ID: 921404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant activities of delta-8 and delta-9 tetrahydrocannabinol and uridine.
    Dwivedi C; Harbison RD
    Toxicol Appl Pharmacol; 1975 Mar; 31(3):452-8. PubMed ID: 1145630
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticonvulsant activity of delta9-tetrahydrocannabinol compared with three other drugs.
    Sofia RD; Solomon TA; Barry H
    Eur J Pharmacol; 1976 Jan; 35(1):7-16. PubMed ID: 1253828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monohydroxylated metabolites of delta-1-tetrahydrocannabinol in mouse brain. Comparison with in vitro liver metabolites.
    Jones G; Widman M; Agurell S; Lindgren JE
    Acta Pharm Suec; 1974 Jun; 11(3):283-94. PubMed ID: 4839738
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of the effects of phenytoin and phenobarbital on electrically induced maximal seizures in frogs and mice.
    Johnson SW; Riker WK
    J Pharmacol Exp Ther; 1982 Apr; 221(1):132-8. PubMed ID: 6977640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin.
    Bland TM; Haining RL; Tracy TS; Callery PS
    Biochem Pharmacol; 2005 Oct; 70(7):1096-103. PubMed ID: 16112652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of SKF-525-A on the metabolism of (minus)-delta9-tetrahydrocannabinol in the rat brain and liver.
    Estevez VS; Englert LF; Ho BT
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):389-92. PubMed ID: 4851722
    [No Abstract]   [Full Text] [Related]  

  • 12. Reassessment of the anticonvulsant activity of alpha, alpha-diphenyl-succinimide.
    Jones MF; Jones GL; Amato RJ; Peyton GA; Wimbish GH
    Proc West Pharmacol Soc; 1980; 23():171-4. PubMed ID: 7403123
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticonvulsant effects of acute and chronic phenytoin treatment in Rana pipiens.
    Johnson SW; Riker WK
    Proc West Pharmacol Soc; 1980; 23():413-7. PubMed ID: 6967605
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of three monohydroxyacid and two dihydroxyacid metabolites of delta 1-tetrahydrocannabinol in mouse liver.
    Harvey DJ; Paton WD
    Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):585-99. PubMed ID: 1265340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the relative anticonvulsant and toxic activities of delta9-tetrahydrocannabinol and its congeners.
    Karler R; Cely W; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):353-8. PubMed ID: 4818378
    [No Abstract]   [Full Text] [Related]  

  • 16. The anticonvulsant activity of cannabinoids in seizure sensitive gerbils.
    Cox B; ten Ham M; Loskota WJ; Lomax P
    Proc West Pharmacol Soc; 1975; 18():154-7. PubMed ID: 1178662
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of anticonvulsant drugs on the number of afferent stimuli needed to cause a hippocampal seizure discharge.
    Izquierdo I
    Pharmacology; 1974; 11(3):146-50. PubMed ID: 4831803
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of seizures and anticonvulsant agents on hippocampal RNA concentration.
    Tannhauser M; Izquierdo I
    Pharmacology; 1974; 11(3):139-45. PubMed ID: 4831802
    [No Abstract]   [Full Text] [Related]  

  • 19. Imperatorin enhances the protective activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Glowniak K; Czuczwar SJ
    Eur J Pharmacol; 2007 Nov; 574(2-3):133-9. PubMed ID: 17651727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta9-tetrahydrocannabinol and 11-hydroxy-delta9-tetrahydrocannabinol: behavioral effects and tolerance development.
    Kosersky DS; McMillan DE; Harris LS
    J Pharmacol Exp Ther; 1974 Apr; 189(1):61-5. PubMed ID: 4823300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.